Skip to main content

Table 5 Costs and clinical resources, by NASG timing group and country

From: Cost-effectiveness of the non-pneumatic anti-shock garment (NASG): evidence from a cluster randomized controlled trial in Zambia and Zimbabwe

Costs and clinical resources All women Zimbabwe Zambia
  832 women in 38 clusters 305 women in 12 clusters 527 women in 12 clusters
  Late Early p-value Late Early p-value Late Early p-value
1. Number of women 466 366   139 166   327 200  
2. Proportion of women who received any blood transfusions 36.1% 27.9%   7.9% 5.8%   48.0% 61.0%  
3. Mean cost of blood transfusions (of those who received blood) $114.88 $115.49 0.967 $500.91 $441.25 0.667 $87.83 $94.14 0.240
4. Proportion of women who received any uterotonics 78.8% 78.4%   82.0% 82.5%   77.4% 75.0%  
5. Mean cost of uterotonics (of those who received uterotonics) $4.53 $7.42 <0.001 $13.46 $14.85 0.332 $0.52 $0.64 < 0.001
6. Mean cost per woman $52.61 $54.56 0.765 $58.30 $41.14 0.275 $50.19 $65.70 < 0.001
  (43.6 - 61.6) (45.6 - 63.5)   (31.3 - 85.2) (23.9 - 58.3)   (44.2 - 56.2 (57.8 - 73.5)  
  1. Note: Wilcoxon Rank Sum test utilized to test all continuous variables due to non-normality.